Art. 30 OTC transactions
1OTC transactions may only be concluded on the basis of a standardised framework agreement which complies with the pertinent international standards. 2The counterparty must:
3It must be possible to reliably and verifiably value an OTC derivative on a daily basis and to sell or close out the derivative at market value at any time. 4If the market price for an OTC derivative is not available, it must be possible at all times to determine the price at any time using appropriate valuation models that are recognised in practice, based on the market value of the underlyings from which the derivative was derived; 5Before concluding a contract for a derivative under paragraph 4, specific offers must be obtained from at least two potential counterparties. The contract is to be concluded with the counterparty providing the most favourable offer in terms of price. A deviation from this principle is possible for reasons relating to risk diversification, or where other parts of the contract such as credit rating or the range of services offered by the counterparties in another offer seem are more advantageous overall for the investors. 6If it is in the investors’ best interests, obtaining offers from at least two potential counterparties may be dispensed with. The reasons for doing so must be clearly documented. 7The conclusion of the transaction and pricing must be clearly documented. |